AUGUST 2023LIFE SCIENCES REVIEW3Structure Free AI-Powered Drug Design PartnerCONTACT UScontact@deargen.medeargen.mewww.linkedin.com/company/deargen/DRUG DISCOVERY PLATFORMOur SolutionsDEARGEN's AI Platforms supports the early Drug Discovery processand accelerates the overall Drug Development process.Target ValidationPredict Target's role in a diseaseDesign of in silico compound librariesIdentify novel targetsPredict signalling of systemsPredict druggability of targetsHit Identification · ValidationPredict of Protein-Compound Binding Affinity (DearDTI)Predict of Protein-Compound Interaction (DearDTE, agonist)Drug Screening for Hit/Lead discoveryDrug RepurposingPolypharmacology Profiling (OFF Target / Multi Target analysis)Lead Identification · ValidationOptimization (ADMET - ex) QSAR etc.)Novel Small Molecule Drug DesignDearTRANS·····DearDTI·····DearDTE·MolEQ··DEARGENTarget Discovery& ValidationDearTRANSHit Discovery& Lead ValidationLead OptimizationMolEQDearDTIDearDTEDRUG DISCOVERY PLATFORMOur SolutionsDEARGEN's AI Platforms supports the early Drug Discovery processand accelerates the overall Drug Development process.Target ValidationPredict Target's role in a diseaseDesign of in silico compound librariesIdentify novel targetsPredict signalling of systemsPredict druggability of targetsHit Identification · ValidationPredict of Protein-Compound Binding Affinity (DearDTI)Predict of Protein-Compound Interaction (DearDTE, agonist)Drug Screening for Hit/Lead discoveryDrug RepurposingPolypharmacology Profiling (OFF Target / Multi Target analysis)Lead Identification · ValidationOptimization (ADMET - ex) QSAR etc.)Novel Small Molecule Drug DesignDearTRANS·····DearDTI·····DearDTE·MolEQ··DEARGENTarget Discovery& ValidationDearTRANSHit Discovery& Lead ValidationLead OptimizationMolEQDearDTIDearDTE
< Page 2 | Page 4 >